Tinavi Medical TechnologiesLtd Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Jin Xu

Chief executive officer

CN¥1.2m

Total compensation

CEO salary percentage	n/a
CEO tenure	no data
CEO ownership	0.07%
Management average tenure	no data
Board average tenure	5.3yrs

Recent management updates

Recent updates

More Unpleasant Surprises Could Be In Store For Tinavi Medical Technologies Co.,Ltd.'s (SHSE:688277) Shares After Tumbling 26%

Apr 21

There's Reason For Concern Over Tinavi Medical Technologies Co.,Ltd.'s (SHSE:688277) Massive 25% Price Jump

Mar 06

Health Check: How Prudently Does Tinavi Medical TechnologiesLtd (SHSE:688277) Use Debt?

Feb 27

CEO

Jin Xu (49 yo)

no data

Tenure

CN¥1,171,000

Compensation

Mr. Jin Xu serves as the General Manager and Director of TINAVI Medical Technologies Co., Ltd.

Board Members

Name	Position	Tenure	Compensation	Ownership
Jin Xu	GM & Director	no data	CN¥1.17m	0.071% CN¥ 2.9m
Changjiu Dai	Independent Director	5.1yrs	CN¥100.00k	no data
Dequan Zhu	Director	13.6yrs	no data	no data
Zhi Xiao	Director	5.5yrs	no data	no data
Yan Li	Independent Director	5.1yrs	CN¥100.00k	no data
Songgen Zhang	Chairman	13.6yrs	CN¥1.22m	16.84% CN¥ 677.9m
Binbin Wang	Director	8.3yrs	CN¥976.00k	0.024% CN¥ 985.7k
Guangzhi Wang	Independent Director	5.1yrs	CN¥100.00k	no data
Zhaoqi Zhu	Supervisor	3.7yrs	no data	no data

5.3yrs

Average Tenure

57yo

Average Age

Experienced Board: 688277's board of directors are considered experienced (5.3 years average tenure).

Tinavi Medical TechnologiesLtd Management

Management criteria checks 2/4

Key information

Recent management updates

Less than half of directors are independent

Recent updates

Full year 2023 earnings released: CN¥0.35 loss per share (vs CN¥0.26 loss in FY 2022)

More Unpleasant Surprises Could Be In Store For Tinavi Medical Technologies Co.,Ltd.'s (SHSE:688277) Shares After Tumbling 26%

Tinavi Medical Technologies Co.,Ltd. to Report Q1, 2024 Results on Apr 27, 2024

There's Reason For Concern Over Tinavi Medical Technologies Co.,Ltd.'s (SHSE:688277) Massive 25% Price Jump

Full year 2023 earnings released: CN¥0.36 loss per share (vs CN¥0.26 loss in FY 2022)

Health Check: How Prudently Does Tinavi Medical TechnologiesLtd (SHSE:688277) Use Debt?

Third quarter 2023 earnings released: CN¥0.082 loss per share (vs CN¥0.088 loss in 3Q 2022)

Second quarter 2023 earnings released: CN¥0.093 loss per share (vs CN¥0.039 loss in 2Q 2022)

TINAVI Medical Technologies Co., Ltd. to Report Q2, 2023 Results on Aug 23, 2023

Full year 2022 earnings released: CN¥0.26 loss per share (vs CN¥0.19 loss in FY 2021)

Full year 2022 earnings released: CN¥0.27 loss per share (vs CN¥0.19 loss in FY 2021)

Beijing Huilin Oriental Technology Partnership Enterprise (Limited Partnership) and Wang Binbin entered into an agreement to acquire 12% stake in Beijing Shuimu Dongfang Medical Robotics Technology Innovation Center Co., Ltd. from TINAVI Medical Technologies Co., Ltd. (SHSE:688277).

Less than half of directors are independent

Third quarter 2022 earnings released: CN¥0.088 loss per share (vs CN¥0.06 loss in 3Q 2021)

Second quarter 2022 earnings released: CN¥0.039 loss per share (vs CN¥0.031 loss in 2Q 2021)

First quarter 2022 earnings released: CN¥0.07 loss per share (vs CN¥0.06 loss in 1Q 2021)

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Third quarter 2021 earnings released: CN¥0.06 loss per share (vs CN¥0.04 loss in 3Q 2020)

Second quarter 2021 earnings released: CN¥0.031 loss per share (vs CN¥0.049 loss in 2Q 2020)

TINAVI Medical Technologies Co., Ltd. announced that it expects to receive CNY 1.34 billion in funding

First quarter 2021 earnings released: CN¥0.06 loss per share (vs CN¥0.04 loss in 1Q 2020)

Full year 2020 earnings released: CN¥0.14 loss per share (vs CN¥0.08 loss in FY 2019)

New 90-day low: CN¥34.82

New 90-day low: CN¥45.92

New 90-day low: CN¥55.62

TINAVI Medical Technologies Co., Ltd. to Report First Half, 2020 Results on Aug 25, 2020

CEO

Tenure

Compensation

Board Members

Average Tenure

Average Age